Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New 5-HT3 receptor ligand with agonist activity in the gut

Sep. 5, 1997

AWD-140-190: new anticonvulsant with favorable efficacy and safety profile

Sep. 5, 1997

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

Sep. 5, 1997

Nicotinic agonist protects against neuronal cell death in rodents

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Beneficial effects of TDN-345 in animal models of cerebrovascular disease

Sep. 5, 1997

Generic methylphenidate approved in U.S.

Sep. 5, 1997

NeuroSearch compound enters phase I for treatment of dementia

Sep. 4, 1997

Neurobiological Technologies files IND for antiedema agent

Sep. 4, 1997

Subtype-selective NMDA receptor ligands reported

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...